| Christie Jane Zocher, | |
|
200 Nw Avenue M Apt 223, Andrews, TX 79714-3532 | |
| (432) 209-4843 | |
| Not Available |
| Full Name | Christie Jane Zocher |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 200 Nw Avenue M Apt 223, Andrews, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053924159 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 211679 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christie Jane Zocher, 200 Nw Avenue M Apt 223, Andrews, TX 79714-3532 Ph: (432) 209-4843 | Christie Jane Zocher, 200 Nw Avenue M Apt 223, Andrews, TX 79714-3532 Ph: (432) 209-4843 |
News Archive
Some viruses come from animals and jump to humans to cause disease. In the case of the novel coronavirus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?
Nature News reports on last week's announcement of preliminary results from a large clinical trial testing the efficacy of GlaxoSmithKline's (GSK) RTS,S malaria vaccine, writing that while media coverage of the announcement touted it as a "big breakthrough in the long campaign to create a malaria vaccine," "several leading vaccine researchers, who are critical of the unusual decision to publish partial trial data, argue that the results raise questions about whether the RTS,S/AS01 candidate vaccine can actually win approval."
Anadis Ltd, a biopharmaceutical company focused on research, development and production of immune milk (colostrum)-derived polyclonal antibodies and other proteins to address major diseases, today announces the initiation of a clinical trial with top clinical scientists at Tel Aviv Sourasky Medical Center in Israel.
People with a severe type of migraine in which one side of the body becomes weak should consider genetic testing, according to research that has found familial genes for this type of migraine in people who did not have family members experiencing the problem.
Targeted therapy with BRAF-MEK inhibitors is an effective treatment for patients with advanced melanoma that cannot be surgically removed or has spread to other areas of the body.
› Verified 7 days ago
Sandra Eades, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2874 Se 4391, Andrews, TX 79714 Phone: 432-924-4892 | |
Maria Valdivia, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 605 Ne 5th St, Andrews, TX 79714 Phone: 325-725-4806 | |
Raquel Reyes, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 901 Sw 1st St, Andrews, TX 79714 Phone: 432-640-7787 |